Omeros (OMER) Leases (2011 - 2026)
Omeros recorded quarterly Leases of $9.5 million in Q1 2026, down 11.11% quarter-over-quarter from $10.7 million in Q4 2025, and down 31.76% year-over-year from $13.9 million in Q1 2025.
Omeros' Leases history runs 12 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- In Q1 2026, Leases fell 31.76% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (down 31.76% YoY), while the FY2025 annual figure was $10.7 million, down 28.43% from the prior year.
- Leases came in at $9.5 million for Q1 2026 at Omeros, down from $10.7 million in the prior quarter.
- In the past five years, Leases ranged from a high of $23.1 million in Q2 2022 to a low of $9.5 million in Q1 2026.
- A 5-year average of $17.3 million and a median of $17.8 million in 2024 frame the typical range for Leases.
- Across the five-year window, Leases declined 8.22% in 2023 and sank 31.76% in 2026, its largest moves.
- Omeros' Leases stood at $21.8 million in 2022, then fell by 14.39% to $18.6 million in 2023, then fell by 19.7% to $15.0 million in 2024, then dropped by 28.43% to $10.7 million in 2025, then slipped by 11.11% to $9.5 million in 2026.
- According to Business Quant data, Leases over the past three periods registered $9.5 million, $10.7 million, and $11.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 9.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.52 Mn |
| Dec 31, 2025 | 10.71 Mn |
| Sep 30, 2025 | 11.81 Mn |
| Jun 30, 2025 | 12.89 Mn |
| Mar 31, 2025 | 13.95 Mn |
| Dec 31, 2024 | 14.96 Mn |
| Sep 30, 2024 | 15.93 Mn |
| Jun 30, 2024 | 16.87 Mn |
| Mar 31, 2024 | 17.77 Mn |
| Dec 31, 2023 | 18.63 Mn |
| Sep 30, 2023 | 19.46 Mn |
| Jun 30, 2023 | 20.26 Mn |
| Mar 31, 2023 | 21.03 Mn |
| Dec 31, 2022 | 21.76 Mn |
| Sep 30, 2022 | 22.46 Mn |
| Jun 30, 2022 | 23.13 Mn |
| Mar 31, 2022 | 22.91 Mn |
| Dec 31, 2021 | 28.28 Mn |
| Sep 30, 2021 | 29.04 Mn |
| Jun 30, 2021 | 29.82 Mn |
| Mar 31, 2021 | 24.99 Mn |
| Dec 31, 2020 | 25.53 Mn |
| Sep 30, 2020 | 26.12 Mn |
| Jun 30, 2020 | 26.60 Mn |
| Mar 31, 2020 | 27.08 Mn |
| Dec 31, 2019 | 27.08 Mn |
| Sep 30, 2019 | 21.30 Mn |
| Jun 30, 2019 | 17.32 Mn |
| Mar 31, 2019 | 17.51 Mn |
| Dec 31, 2014 | 230,000.00 |
| Dec 31, 2013 | 231,000.00 |
| Dec 31, 2012 | 231,000.00 |
| Dec 31, 2011 | 201,000.00 |